Waldron Private Wealth LLC Pfizer Inc Transaction History

Waldron Private Wealth LLC

$2.23 Billion
Q2 2024

A detailed history of Waldron Private Wealth LLC transactions in Pfizer Inc stock. As of the latest transaction made, Waldron Private Wealth LLC holds 59,340 shares of PFE stock, worth $1.76 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

59,340

Previous 54,497 8.89%

Holding current value

$1.76 Million

Previous $1.51 Million 9.79%

% of portfolio

0.07%

Previous 0.07%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $122,334 - $143,352	4,843 Added 8.89%	59,340 $1.66 Million
Q1 2024 May 09, 2024	SELL	$25.89 - $29.73 $5,747 - $6,600	-222 Reduced 0.41%	54,497 $1.51 Million
Q4 2023 Aug 29, 2024	SELL	$26.13 - $33.94 $9,798 - $12,727	-375 Reduced 0.68%	54,719 $1.58 Million
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $9,798 - $12,727	-375 Reduced 0.68%	54,719 $1.58 Million
Q3 2023 Aug 29, 2024	SELL	$32.09 - $37.51 $198,733 - $232,299	-6,193 Reduced 10.1%	55,094 $1.83 Million
Q3 2023 Oct 26, 2023	SELL	$32.09 - $37.51 $198,733 - $232,299	-6,193 Reduced 10.1%	55,094 $1.83 Million
Q2 2023 Aug 29, 2024	SELL	$36.12 - $41.79 $124,975 - $144,593	-3,460 Reduced 5.34%	61,287 $2.25 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $124,975 - $144,593	-3,460 Reduced 5.34%	61,287 $2.25 Million
Q1 2023 Aug 29, 2024	BUY	$39.39 - $51.28 $212,981 - $277,270	5,407 Added 9.11%	64,747 $2.64 Million
Q1 2023 May 02, 2023	BUY	$39.39 - $51.28 $210,145 - $273,578	5,335 Added 8.98%	64,747 $2.64 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $60,695 - $74,093	-1,387 Reduced 2.28%	59,412 $2.6 Million
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $146,755 - $174,006	3,154 Added 5.47%	60,799 $3.19 Million
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $93,238 - $115,534	2,038 Added 3.67%	57,645 $2.98 Million
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $7,520 - $11,147	182 Added 0.33%	55,607 $3.28 Million
Q3 2021 Nov 02, 2021	BUY	$39.25 - $50.42 $146,638 - $188,369	3,736 Added 7.23%	55,425 $2.38 Million
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $218,045 - $247,008	6,072 Added 13.31%	51,689 $2.02 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $174,248 - $196,517	-5,203 Reduced 10.24%	45,617 $1.65 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $49,468 - $62,903	-1,478 Reduced 2.83%	50,820 $1.87 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $13,017 - $15,272	410 Added 0.79%	52,298 $1.92 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $8,252 - $10,011	274 Added 0.53%	51,888 $1.7 Million
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $49,816 - $71,176	-1,843 Reduced 3.45%	51,614 $1.68 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $440,601 - $500,026	-13,384 Reduced 20.02%	53,457 $2.09 Million
Q3 2019 Nov 06, 2019	BUY	$32.49 - $42.13 $484,003 - $627,610	14,897 Added 28.68%	66,841 $2.4 Million
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $109,164 - $122,567	-2,952 Reduced 5.38%	51,944 $2.25 Million
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $1.14 Million - $1.25 Million	30,286 Added 123.06%	54,896 $2.33 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $161,881 - $184,562	4,208 Added 20.63%	24,610 $1.07 Million
Q3 2018 Nov 20, 2018	BUY	$34.47 - $41.81 $14,546 - $17,643	422 Added 2.11%	20,402 $899,000
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $125,488 - $133,783	-3,805 Reduced 16.0%	19,980 $724,000
Q4 2017 Jan 26, 2018	BUY	$33.26 - $35.29 $44,601 - $47,323	1,341 Added 5.97%	23,785 $861,000
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $101,215 - $111,499	3,265 Added 17.02%	22,444 $801,000
Q2 2017 Aug 14, 2017	BUY	N/A	19,179	19,179 $644,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waldron Private Wealth LLC with notifications on news.

Account

Waldron Private Wealth LLC Pfizer Inc Transaction History